Videos and Publications

Videos

Shooting for the Moon Against Cancer

Vetigenics co-founder, Dr. Nicola Mason spotlights the ambitious Cancer Moonshot initiative and how translational medicine is helping both pets and humans.

Breakthrough Together
Check out Dr. Mason’s groundbreaking efforts to advance immunotherapy for dogs and humans. This approach has the potential to fast-track progress in cancer medicine across species – a united front against cancer.
Dr. Mason Reveals Comparative Oncology’s Promise on 60 Minutes
Featured on 60 Minutes, Dr. Mason explains how comparing human and canine cancers can transform treatment for all. She highlights stunning genetic similarities allowing dogs to model human disease. This emerging field has already achieved breakthroughs by uniting human medicine and our best friends.

Publications

Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors

Sho Yoshimoto, Nicholas Chester, Ailian Xiong, Enrico Radaelli, Hong Wang, Marc Brillantes, Gayathri Gulendran, Patrick Glassman, Don L. Siegel & Nicola J. Mason

Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors

Nicola J. Mason, Nicholas Chester, Ailian Xiong, Antonia Rotolo, Ying Wu, Sho Yoshimoto, Patrick Glassman, Gayathri Gulendran & Don L. Siegel

.elementor-icon, a.skip-link{display:none!important;} .print-img img{margin:0 auto!important} .elementor-element-23751c5 img.attachment-full {max-width:100%!important} .dogs.print-no{display:none!important;} .print-text-align-center{text-align:center!important;} img.attachment-full.size-full.wp-image-1769.pf-large-image.pf-primary-img.flex-width.pf-size-small.mediumImage { display: none!important; }